Genital Diseases, Female  >>  Ovidrel (choriogonadotropin alfa)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ovidrel (choriogonadotropin alfa) / EMD Serono
NCT00953628: Endometrial Advancement After Rec or u-HCG Triggering

Completed
4
130
Europe
10000 IU urinary HCG, Pregnyl, 250 mcg recombinant HCG, Ovitrelle
Universitair Ziekenhuis Brussel, Merck Serono International SA
Infertility
12/06
12/08

Download Options